CMPX Operating Expenses

Compass Therapeutics · Operating Expenses

CMPX logo

CMPX Operating Expenses

Latest reported$80.35M
CMPX TTM Operating Expenses ($34.12M → $80.35M)
High-resolution chart · PNG

CMPX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Compass Therapeutics Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
80,347,000
74,434,000
72,469,000
71,423,000
67,845,000
62,674,000
57,478,000
56,297,000
55,984,000
53,426,000
50,367,000
47,862,000
48,534,000
44,184,000
41,655,000
41,768,000
35,024,000
81,726,000
81,883,000
76,832,000
79,939,000
29,320,000
27,812,000
26,264,000
25,686,000
29,289,000
34,116,000
27,714,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.